Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

AVCT

Avacta (AVCT)

Avacta Group Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:AVCT
FechaHoraFuenteTítuloSímboloCompañía
01/05/202405:53Alliance NewsAlliance NewsIN BRIEF: Avacta picks Christina Coughlin to replace long-serving CEOLSE:AVCTAvacta Group Plc
30/04/202410:30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:AVCTAvacta Group Plc
30/04/202401:01RNS Regulatory NewsAvacta Group PLC Full Year ResultsLSE:AVCTAvacta Group Plc
30/04/202401:00RNS Regulatory NewsAvacta Group PLC Board ChangeLSE:AVCTAvacta Group Plc
26/04/202403:51RNS Regulatory NewsAvacta Group PLC Block listing Interim Return REPLACEMENTLSE:AVCTAvacta Group Plc
26/04/202401:00RNS Regulatory NewsAvacta Group PLC Block Listing Six Monthly ReturnLSE:AVCTAvacta Group Plc
23/04/202403:43RNS Regulatory NewsAvacta Group PLC Block Listing Application to AIMLSE:AVCTAvacta Group Plc
23/04/202401:00RNS Regulatory NewsAvacta Group PLC Notice of ResultsLSE:AVCTAvacta Group Plc
22/04/202411:51Alliance NewsAlliance NewsTRADING UPDATES: First Tin updates Tellerhauser estimatesLSE:AVCTAvacta Group Plc
22/04/202406:14RNS Regulatory NewsAvacta Group PLC Issue of Equity and Total Voting RightsLSE:AVCTAvacta Group Plc
09/04/202411:00RNS Regulatory NewsAvacta Group PLC Avacta Reports Data at the AACR Annual MeetingLSE:AVCTAvacta Group Plc
08/04/202401:00RNS Regulatory NewsAvacta Group PLC AVA6000 Abstract Release by AACRLSE:AVCTAvacta Group Plc
05/04/202415:30UK RegulatoryAvacta Group - AVA6000 Abstract Release by AACR and Full Presentation UpdateLSE:AVCTAvacta Group Plc
28/03/202411:00RNS Non-RegulatoryAvacta Group PLC Investor WebinarLSE:AVCTAvacta Group Plc
21/03/202405:37Alliance NewsAlliance NewsAvacta doses third patient in drug conjugate trial for tumour tissueLSE:AVCTAvacta Group Plc
21/03/202402:00RNS Regulatory NewsAvacta Group PLC Update on AVA6000 Phase 1a Clinical Trial ProgressLSE:AVCTAvacta Group Plc
18/03/202409:31Alliance NewsAlliance NewsIN BRIEF: Avacta shareholders give AGM go-ahead to issue new sharesLSE:AVCTAvacta Group Plc
18/03/202408:26RNS Regulatory NewsAvacta Group PLC Result of General MeetingLSE:AVCTAvacta Group Plc
06/03/202401:00RNS Regulatory NewsAvacta Group PLC Avacta Announces AVA6000 Poster at AACRLSE:AVCTAvacta Group Plc
05/03/202415:30UK RegulatoryUpdated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024LSE:AVCTAvacta Group Plc
05/03/202411:09Alliance NewsAlliance NewsEARNINGS AND TRADING: Harland & Wolff wins major Falklands contractLSE:AVCTAvacta Group Plc
05/03/202401:00RNS Regulatory NewsAvacta Group PLC Result of REX Retail OfferLSE:AVCTAvacta Group Plc
29/02/202406:18Alliance NewsAlliance NewsAvacta increases placing size to GBP26 million thanks to strong demandLSE:AVCTAvacta Group Plc
29/02/202401:00RNS Regulatory NewsAvacta Group PLC Result of PlacingLSE:AVCTAvacta Group Plc
28/02/202414:31Alliance NewsAlliance NewsTRADING UPDATES: Avacta plans fundraise to fund clinical developmentLSE:AVCTAvacta Group Plc
28/02/202410:42RNS Regulatory NewsAvacta Group PLC Proposed REX Retail OfferLSE:AVCTAvacta Group Plc
28/02/202410:41RNS Regulatory NewsAvacta Group PLC Proposed Fundraise to progress TherapeuticsLSE:AVCTAvacta Group Plc
16/02/202401:00RNS Regulatory NewsAvacta Group PLC Share Incentive Plan/Issue of EquityLSE:AVCTAvacta Group Plc
19/01/202403:11Alliance NewsAlliance NewsIN BRIEF: Avacta says new head of R&D Coughlin brings "deep expertise"LSE:AVCTAvacta Group Plc
19/01/202401:00UK RegulatoryAvacta Group PLC Appointment of Christina CoughlinLSE:AVCTAvacta Group Plc
 Showing the most relevant articles for your search:LSE:AVCT

Su Consulta Reciente

Delayed Upgrade Clock